Clinical trial · Interventional
The Effect of Motivational Interviewing on HPV-DNA Testing
The Effect of Health Belief Model-Based Motivational Interviews on Women's HPV-DNA Testing According to the Precautionary Acceptance Process
NCT06662136CI-TRIAL-00102305completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this randomized controlled study was to examine the effects of Health Belief Model Based Motivational Interviewing on HPV-DNA testing in women according to the Precautionary Acceptance Process.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancers | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| motivasional intereview | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Experimental group
- description
- Participants in the experimental group will be given motivational interviews about HPV at 4 different times and will also be given an educational brochure.
- interventionNames
- Behavioral: motivasional intereview
- type
- NO_INTERVENTION
- label
- control group
- description
- Participants in the control group will not receive any intervention
Primary outcomes (1)
- measure
- Learning about HPV
- timeFrame
- From the beginning of the study until the 4th month.
- description
- The program was planned as 4 sessions and the duration of the interview was 20-30 minutes. The women in the experimental group will be given 4 motivational interviews and a training brochure. Questionnaire/scale forms will be administered 4 times in total: The scales will be administered as a pre-test before the intervention, an interim test after the second motivational interview, a final test after the fourth motivational interview, and a final test two months after the last interview. The total score to be obtained from HPV-BÖ is between 0-33 and a high score indicates a high level of knowledge about HPV, HPV screening tests and the HPV vaccine The "Cervical Cancer and Pap-smear Test Health Belief Model Scale" will be used to understand the situations that prevent women from taking the HPV-DNA test.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 30 Years
- Maximum age
- 45 Years
Show eligibility criteria text
Inclusion Criteria: * Women aged 30-45 registered at Family Health Centre No. 1, * Who currently have or have had an active sex life, * Women who have not undergone an HPV-DNA test in the last five years, * Women who can read and write, have no communication problems, and can use a smartphone and WhatsApp, * Women with no diagnosed psychiatric problems, * Women who agreed to participate in the study. Exclusion Criteria: * Women who were unable to complete the entire study due to any circumstances during the data collection phases, * Women who voluntarily withdrew from the study were excluded.
References
Publications (2)
- RESULTLewandowska AM, Lewandowski T, Rudzki M, Rudzki S, Laskowska B. Cancer prevention - review paper. Ann Agric Environ Med. 2021 Mar 18;28(1):11-19. doi: 10.26444/aaem/116906. Epub 2020 Mar 12. PMID 33775063
- RESULTGhasemi M, Savabi-Esfahani M, Noroozi M, Satari M. Prediction of cervical cancer screening: application of the information-motivation-behavioral skills model. BMC Cancer. 2024 Mar 19;24(1):351. doi: 10.1186/s12885-024-12098-9. PMID 38504202